funder-graph

FundersOH

Grants paid by Siegel Rare Neuroimmune Association

EIN 91-1780467 · Powell, OH · Form 990, Schedule I · NTEE G99

Siegel Rare Neuroimmune Association of Powell, OH (EIN 91-1780467) reported 10 grants paid totaling $311,477 to 5 recipients in tax years 2020–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$311,477

10 grants

Recipients

5

distinct organizations

Tax years

2020–2024

4 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20203$41,477
20222$52,500
20232$80,000
20243$137,500

Top recipients

The 5 recipients receiving the most from Siegel Rare Neuroimmune Association, by grants paid, out of 5 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Massachusetts General Hospital 04-1564655ABoston, MA3$127,5002024
Johns Hopkins School of Medicine 52-0595110ABaltimore, MD2$80,0002024
University of Utah 87-6000525ASalt Lake City, UT2$70,0002024
University of Texas Southwestern Medical Center 75-6002868ADallas, TX2$28,2272022
The Sumaira Foundation for Nmo 47-2398246DBrookline, MA1$5,7502020

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 10 grant rows this organization reported, most recent first.

Grants reported by Siegel Rare Neuroimmune Association
Tax yearRecipientMatchAmountTypePurposeSource filing
2024University of Utah Salt Lake City, UTA$50,000paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroimmune disorders and a second grant to study the Effects of Social Determinants of Health Factors in Transverse Myelitis:Epidemiology of the National Veterans Health Administration Population202543149349304779
2024Massachusetts General Hospital Boston, MAA$47,500paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroiummune diseases and a second grant to investigate Headache and Eye Pain Associated with Rare Neuroimmune Disorders202543149349304779
2024Johns Hopkins School of Medicine Baltimore, MDA$40,000paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroiummune diseases202543149349304779
2023Massachusetts General Hospital Boston, MAA$40,000paidAcquired samples of CSF and blood from TM,MS,NMO,MOG patients and healthy controls. Using artificially produced exosomes in culture from cell lines , she successfully improved on a protocol to purify and characterize exosomes. These exosomes are within a specific size range and contain the markers of exosomes (tetraspanins). From MOG-expressing HEK cells, she can identify MOG protein within the exosomes and from AQP4-expressing HEK cells, she can identify AQP4 on the membranes of exosomes.202442849349300714
2023Johns Hopkins Univ School of Medicine Baltimore, MDA$40,000paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroiummune diseases202442849349300714
2022Massachusetts General Hospital Boston, MAA$40,000paidAcquired samples of CSF and blood from TM,MS,NMO,MOG patients and healthy controls. Using artificially produced exosomes in culture from cell lines , she successfully improved on a protocol to purify and characterize exosomes. These exosomes are within a specific size range and contain the markers of exosomes (tetraspanins). From MOG-expressing HEK cells, she can identify MOG protein within the exosomes and from AQP4-expressing HEK cells, she can identify AQP4 on the membranes of exosomes.202322789349301752
2022University of Texas Southwestern Medical Center Dallas, TXA$12,500paidGrant will be used to assess condition specific knowledge of patients with rare neuroimmue disorders202322789349301752
2020University of Utah Salt Lake City, UTA$20,000paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroimmune disorders202143149349306189
2020University of Texas Southwestern Medical Center Dallas, TXA$15,727paidFellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroimmune disorders202143149349306189
2020The Sumaira Foundation for Nmo Brookline, MAD$5,750paidOrganization and member participation in podcast series and community grant202143149349306189

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020242024-12-31not stated2024v5.0202543149349304779
99020232023-12-31not stated2023v5.0202442849349300714
99020222022-12-31not stated2022v5.0202322789349301752
99020202020-12-31not stated2020v4.0202143149349306189

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/911780467.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.